Search Result "biological equivalent dose"
Demonstration of Biological and Immunological Equivalence of a Generic Glatiramer Acetate
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16 Issue: 6 Year: 2017 Page: 714-723
Author(s): Josephine D`Alessandro,Kevin Garofalo,Ganlin Zhao,Christopher Honan,Jay Duffner,Ishan Capila,Ian Fier,Ganesh Kaundinya,Daniel Kantor,Tanmoy Ganguly
Maternal Nutrient Restriction is not Equivalent to Maternal Biological Stress
Journal: Current Drug Targets
Volume: 8 Issue: 8 Year: 2007 Page: 888-893
Author(s): Helen Budge, Terence Stephenson, Michael E. Symonds
The Case of Biotech-Derived Product Equivalence: Much Ado About Nothing?
Journal: Current Clinical Pharmacology
Volume: 1 Issue: 2 Year: 2006 Page: 147-156
Author(s): Jorge Duconge
Patient Radiation Doses in Interventional Cardiology Procedures
Journal: Current Cardiology Reviews
Volume: 5 Issue: 1 Year: 2009 Page: 1-11
Author(s): Ioannis Pantos, Georgios Patatoukas, Demosthenes G. Katritsis, Efstathios Efstathopoulos
Cellular and Molecular Surrogate Markers to Monitor Targeted and Non- Targeted Antiangiogenic Drug Activity and Determine Optimal Biologic Dose
Journal: Current Cancer Drug Targets
Volume: 5 Issue: 7 Year: 2005 Page: 551-559
Author(s): Yuval Shaked, Guido Bocci, Raquel Munoz, Shan Man, John M.L. Ebos, Daniel J. Hicklin, Francesco Bertolini, Robert DAmato, Robert S. Kerbel
In Vitro Evaluation of Chloroaluminum Phthalocyanine Nanoemulsion and Low-Level Laser Therapy on Human Skin Dermal Equivalents and Bone Marrow Mesenchymal Stem Cells
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 2 Year: 2011 Page: 3376-3381
Author(s): F. L. Primo, M. B. da Costa Reis, M. A. Porcionatto, A. C. Tedesco
Photobiostimulation on Wound Healing Treatment by ClAlPc-nanoemulsion from a Multiple-Wavelength Portable Light Source on a 3D-Human Stem Cell Dermal Equivalent
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 30 Year: 2012 Page: 5157-5163
Author(s): F.L. Primo,L.B. de Paula,M.P. de Siqueira-Moura,A.C. Tedesco
Identifying the Optimal Fractionation Schedules for Improved Response Rates and Survival in Patients with Metastatic Melanoma Treated with Ipilimumab and Radiotherapy
Journal: Current Cancer Therapy Reviews
Volume: 16 Issue: 1 Year: 2020 Page: 78-85
Author(s): Jason Liu,Cong Xu,Junjia Zhu,Jeffrey Sivik,Joseph J. Drabick,Heath B. Mackley
The Biological Effects of Diagnostic Cardiac Imaging
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 1 Year: 2009 Page: 1123-1130
Author(s): L. Landini, A. Ripoli, M. F. Santarelli, L. Landini Jr., V. Positano
Biological Therapies of Autoimmune Diseases
Journal: Current Drug Targets - Inflammation & Allergy
Volume: 4 Issue: 1 Year: 2005 Page: 41-46
Author(s): Irene S. Kourbeti, Dimitrios T. Boumpas